Skip to main content

Table 5 Adjusted monthly post-index costs for patients with positive costs, US dollars

From: One-year risk of psychiatric hospitalization and associated treatment costs in bipolar disorder treated with atypical antipsychotics: a retrospective claims database analysis

Cost Category Aripiprazole Mean $ (SE) Ziprasidone Mean $ (SE) p-value Aripiprazole Mean $ (SE) Olanzapine Mean $ (SE) p-value Aripiprazole Mean $ (SE) Quetiapine Mean $ (SE) p-value Aripiprazole Mean $ (SE) Risperidone Mean $ (SE) p-value
Psychiatric costs             
   Inpatient/ER 788.70(91.60) 1039.90 (121.70) 0.076 666.90 (61.80) 876.20 (91.70) 0.038 627.60 (56.80) 833.80 (81.00) 0.024 674.40 (61.70) 743.60 (73.50) 0.446
   Outpatient 202.00 (12.50) 271.90 (16.40) <0.001 191.60 (9.70) 207.00 (9.90) 0.210 194.40 (9.20) 232.30 (10.90) 0.003 195.10 (9.50) 206.30 (9.50) 0.351
   Total 487.20 (33.80) 631.20 (43.60) 0.004 447.30 (24.80) 483.70 (27.50) 0.287 429.90 (22.60) 518.80 (28.00) 0.007 449.10 (24.10) 441.50 (23.70) 0.807
General medical costs             
   Inpatient/ER 747.20 (115.10) 686.40 (104.30) 0.687 681.00 (86.80) 372.20 (44.50) <0.001 642.30 (83.70) 790.70 (89.70) 0.220 667.60 (87.40) 966.80 (120.30) 0.038
   Outpatient 398.00 (24.60) 365.20 (23.30) 0.282 372.90 (19.30) 382.80 (20.00) 0.690 386.40 (19.60) 433.80 (21.20) 0.070 384.10 (19.20) 353.60 (17.30) 0.189
   Total 540.20 (36.50) 527.10 (36.40) 0.777 521.60 (28.40) 484.60 (26.50) 0.294 519.40 (28.40) 655.70 (34.00) 0.001 511.10 (27.70) 542.10 (29.20) 0.395
Psychiatric Medical and General Medical costs 961.30 (59.00) 1055.10 (65.90) 0.223 910.00 (45.00) 891.20 (43.80) 0.736 875.00 (42.20) 1,060.30 (50.00) 0.001 898.20 (43.90) 934.30 (45.00) 0.518
Pharmacy costs 286.00 (11.10) 296.10 (11.40) 0.435 281.80 (9.10) 257.20 (8.00) 0.012 288.60 (9.00) 252.80 (7.70) <0.001 282.70 (8.90) 241.00 (7.20) <0.001
TOTAL COSTS 1,308.20 (64.90) 1,406.20 (70.80) 0.229 1,287.40 (51.10) 1,214.00 (47.70) 0.224 1,230.70 (47.70) 1,354.90 (51.70) 0.040 1,252.40 (49.60) 1,216.20 (47.60) 0.540
  1. Results of generalized gamma regression adjusting for pre-index costs in propensity score-matched cohorts